Logo of Robert Koch InstituteLogo of Robert Koch Institute
Publication Server of Robert Koch Instituteedoc
de|en
View Item 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CollectionTitleAuthorSubject
PublishLoginRegisterHelp
StatisticsView Usage Statistics
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CollectionTitleAuthorSubject
PublishLoginRegisterHelp
StatisticsView Usage Statistics
View Item 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
2016-07-21Zeitschriftenartikel DOI: 10.2807/1560-7917.ES.2016.21.29.30292
Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014
Dorp, S. M. van
Notermans, D. W.
Alblas, J.
Gastmeier, Petra
Mentula, S.
Nagy, E.
Spigaglia, P.
Ivanova, K.
Fitzpatrick, F.
Barbut, F.
Morris, T.
Wilcox, M. H.
Kinross, P.
Suetens, C.
Kuijper, Ed J.
Weiß, Bettina
Suboptimal laboratory diagnostics for Clostridium difficile infection (CDI) impedes its surveillance and control across Europe. We evaluated changes in local laboratory CDI diagnostics and changes in national diagnostic and typing capacity for CDI during the European C. difficile Infection Surveillance Network (ECDIS-Net) project, through cross-sectional surveys in 33 European countries in 2011 and 2014. In 2011, 126 (61%) of a convenience sample of 206 laboratories in 31 countries completed a survey on local diagnostics. In 2014, 84 (67%) of these 126 laboratories in 26 countries completed a follow-up survey. Among laboratories that participated in both surveys, use of CDI diagnostics deemed ‘optimal’ or ‘acceptable’ increased from 19% to 46% and from 10% to 15%, respectively (p  
Files in this item
Thumbnail
23FAjrwulRSs.pdf — Adobe PDF — 2.653 Mb
MD5: 2ed2a0bc6c301c1d747c905bc14f0e77
Cite
BibTeX
EndNote
RIS
No license information
Details
Terms of Use Imprint Policy Data Privacy Statement Contact

The Robert Koch Institute is a Federal Institute

within the portfolio of the Federal Ministry of Health

© Robert Koch Institute

All rights reserved unless explicitly granted.

 
DOI
10.2807/1560-7917.ES.2016.21.29.30292
Permanent URL
https://doi.org/10.2807/1560-7917.ES.2016.21.29.30292
HTML
<a href="https://doi.org/10.2807/1560-7917.ES.2016.21.29.30292">https://doi.org/10.2807/1560-7917.ES.2016.21.29.30292</a>